Sarepta Therapeutics Inc (SRPT)
Fixed asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 1,901,980 | 1,243,340 | 933,013 | 701,887 | 540,099 |
| Property, plant and equipment | US$ in thousands | — | — | 244,991 | 191,156 | 190,430 |
| Fixed asset turnover | — | — | 3.81 | 3.67 | 2.84 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $1,901,980K ÷ $—K
= —
The fixed asset turnover ratio measures how efficiently a company is generating revenues from its fixed assets. In the case of Sarepta Therapeutics Inc, the fixed asset turnover ratio has been improving steadily from 2.84 in December 2020 to 3.67 in December 2021 and further to 3.81 in December 2022. This indicates that the company is effectively utilizing its fixed assets to generate sales, which is a positive sign for investors and creditors. However, there is no data available for the years 2023 and 2024, so it is important to monitor future financial statements to assess if this trend continues. Overall, the increasing trend in the fixed asset turnover ratio suggests that Sarepta Therapeutics Inc is efficiently utilizing its fixed assets to drive revenue growth.
Peer comparison
Dec 31, 2024